Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
about
Current research on pharmacologic and regenerative therapies for osteoarthritisOn the predictive utility of animal models of osteoarthritisCalcitonin gene-related peptide in the joint: contributions to pain and inflammationGenes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study.Suppression of Peripheral Pain by Blockade of Voltage-Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model.Painful, degenerating intervertebral discs up-regulate neurite sprouting and CGRP through nociceptive factorsAnti-nerve growth factor antibody attenuates chronic morphine treatment-induced tolerance in the rat.The genetics and functional analysis of primary osteoarthritis susceptibility.Increased TRPV4 expression in urinary bladder and lumbosacral dorsal root ganglia in mice with chronic overexpression of NGF in urothelium.The future of osteoarthritis therapeutics: emerging biological therapy.Biologic agents in osteoarthritis: hopes and disappointments.Nerve growth factor: an update on the science and therapy.Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function.Substance-P in symptomatic mediopatellar plica as a predictor of patellofemoral pain.Identification of long noncoding RNA associated with osteoarthritis in humans.The Changing Sensory and Sympathetic Innervation of the Young, Adult and Aging Mouse Femur.Human Adenomyosis Endometrium Stromal Cells Secreting More Nerve Growth Factor: Impact and Effect.
P2860
Q26766598-391DFDC4-C61C-4AF2-B664-BD5C5618F717Q26781301-B628836A-8472-475A-8F0A-A88D3A63CEE2Q28081771-10E03E5F-F5FC-41EE-BACE-7F2317C8096CQ33940184-B81A7B7D-DD5F-46E8-88A0-744CE11B259AQ35655587-AC3393ED-DD48-47A4-BEAC-396AE0F160AEQ35867969-168D7693-C1A0-4738-BC9A-5E9E7EF5B332Q36123358-4BCE99BD-C025-430E-84BA-05FFBAA167EFQ36620051-5EA409DB-7384-4B3E-99FF-43643EB35340Q37188799-1B854969-09B1-46CA-84D2-0C2B89256454Q37333939-82E5DD84-0F66-4C3C-80AE-88B1F6ECE497Q38094906-2AC985EB-4DB5-46B8-8BCE-F0D3DD4661C5Q38131207-5CCFC3EC-15D1-45E9-963F-B1E734641BA6Q39171371-6493FA74-344A-4E55-A9FC-5732FA49D6E0Q39192100-A972089A-98B8-4248-90F4-878A5F6C0917Q42177454-4565FE10-A167-4360-97CA-879572AABF3DQ45251665-754F41A5-F1F6-40CA-A7EC-66808744AEEAQ50060345-38160717-C282-4FC8-B017-4F618493D514Q53665520-6290CB8E-F739-4BF8-BFDE-FF9077C99347
P2860
Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
@en
type
label
Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
@en
prefLabel
Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
@en
P2860
P1476
Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
@en
P2093
Matthias F Seidel
Nancy E Lane
P2860
P2888
P304
P356
10.1007/S11926-012-0289-8
P577
2012-12-01T00:00:00Z
P6179
1022017988